279 related articles for article (PubMed ID: 31333582)
1. The Development of Gonadotropins for Clinical Use in the Treatment of Infertility.
Lunenfeld B; Bilger W; Longobardi S; Alam V; D'Hooghe T; Sunkara SK
Front Endocrinol (Lausanne); 2019; 10():429. PubMed ID: 31333582
[TBL] [Abstract][Full Text] [Related]
2. The role of gonadotropins in follicular development and their use in ovulation induction protocols for assisted reproduction.
Zafeiriou S; Loutradis D; Michalas S
Eur J Contracept Reprod Health Care; 2000 Jun; 5(2):157-67. PubMed ID: 10943580
[TBL] [Abstract][Full Text] [Related]
3. In vitro fertilisation. A review of drug therapy and clinical management.
Jennings JC; Moreland K; Peterson CM
Drugs; 1996 Sep; 52(3):313-43. PubMed ID: 8875126
[TBL] [Abstract][Full Text] [Related]
4. Efficacy of different gonadotropin combinations to support ovulation induction in WHO type I anovulation infertility: clinical evidences of human recombinant FSH/human recombinant LH in a 2:1 ratio and highly purified human menopausal gonadotropin stimulation protocols.
Carone D; Caropreso C; Vitti A; Chiappetta R
J Endocrinol Invest; 2012 Dec; 35(11):996-1002. PubMed ID: 23095369
[TBL] [Abstract][Full Text] [Related]
5. Gonadotrophins for ovulation induction in women with polycystic ovary syndrome.
Weiss NS; Kostova E; Nahuis M; Mol BWJ; van der Veen F; van Wely M
Cochrane Database Syst Rev; 2019 Jan; 1(1):CD010290. PubMed ID: 30648738
[TBL] [Abstract][Full Text] [Related]
6. A randomized, controlled, first-in-patient trial of choriogonadotropin beta added to follitropin delta in women undergoing ovarian stimulation in a long GnRH agonist protocol.
Fernández Sánchez M; Višnová H; Larsson P; Yding Andersen C; Filicori M; Blockeel C; Pinborg A; Khalaf Y; Mannaerts B;
Hum Reprod; 2022 May; 37(6):1161-1174. PubMed ID: 35451013
[TBL] [Abstract][Full Text] [Related]
7. Stimulation of ovarian follicular maturation with pure follicle-stimulating hormone in women with gonadotropin deficiency.
Couzinet B; Lestrat N; Brailly S; Forest M; Schaison G
J Clin Endocrinol Metab; 1988 Mar; 66(3):552-6. PubMed ID: 3127417
[TBL] [Abstract][Full Text] [Related]
8. Managing infertility with the follitropin alfa prefilled pen injector - patient considerations.
Bühler K
Ther Clin Risk Manag; 2015; 11():995-1001. PubMed ID: 26170678
[TBL] [Abstract][Full Text] [Related]
9. Anti-LHRH and anti-pituitary gonadotropin vaccines: their development and clinical applications.
Thau R
Scand J Immunol Suppl; 1992; 11():127-30. PubMed ID: 1514027
[TBL] [Abstract][Full Text] [Related]
10. Implications of using follicle-stimulating hormone preparations depleted of luteinizing hormone to achieve follicular growth in in vitro fertilization.
Agrawal R; Conway GS; Engmann L; Bekir JS; Jacobs HS
Gynecol Endocrinol; 1998 Feb; 12(1):9-15. PubMed ID: 9526704
[TBL] [Abstract][Full Text] [Related]
11. Efficacy of Follicle-Stimulating Hormone (FSH) Alone, FSH + Luteinizing Hormone, Human Menopausal Gonadotropin or FSH + Human Chorionic Gonadotropin on Assisted Reproductive Technology Outcomes in the "Personalized" Medicine Era: A Meta-analysis.
Santi D; Casarini L; Alviggi C; Simoni M
Front Endocrinol (Lausanne); 2017; 8():114. PubMed ID: 28620352
[TBL] [Abstract][Full Text] [Related]
12. Recombinant-follicle stimulating hormone is more effective than urinary human menopausal gonadotropin in ovarian hyperstimulation for assisted reproductive technology treatment.
Nakagawa K; Ohgi S; Kojima R; Sugawara K; Horikawa T; Ito M; Irahara M; Saito H
Reprod Med Biol; 2007 Mar; 6(1):27-32. PubMed ID: 29657551
[No Abstract] [Full Text] [Related]
13. Disappearance of human chorionic gonadotropin and resumption of ovulation following abortion.
Marrs RP; Kletzky OA; Howard WF; Mishell DR
Am J Obstet Gynecol; 1979 Nov; 135(6):731-6. PubMed ID: 495673
[TBL] [Abstract][Full Text] [Related]
14. [Effect of domestic highly purified urinary follicle stimulating hormone on outcomes of in vitro fertilization-embryo transfer in controlled ovarian stimulation].
Ye H; Huang GN; Cao YX; Zhong Y; Huang YH; Zhu GJ; Zhou LM; Chen ZJ; Shi JZ; Zeng Y; Weng N; Huang XF; Yang J; Zhu YM; Li YP; Yi D; Zhuang GL
Zhonghua Fu Chan Ke Za Zhi; 2013 Nov; 48(11):838-42. PubMed ID: 24444561
[TBL] [Abstract][Full Text] [Related]
15. Endocrine profile following stimulation with recombinant follicle stimulating hormone and luteinizing hormone versus highly purified human menopausal gonadotropin.
Requena A; Cruz M; Ruiz FJ; García-Velasco JA
Reprod Biol Endocrinol; 2014 Jan; 12():10. PubMed ID: 24476504
[TBL] [Abstract][Full Text] [Related]
16. Recombinant gonadotropins.
Lathi RB; Milki AA
Curr Womens Health Rep; 2001 Oct; 1(2):157-63. PubMed ID: 12112963
[TBL] [Abstract][Full Text] [Related]
17. Development of gonadotrophins for clinical use.
Lunenfeld B
Reprod Biomed Online; 2002; 4 Suppl 1():11-7. PubMed ID: 12470330
[TBL] [Abstract][Full Text] [Related]
18. Follicle-stimulating hormone in clinical practice: an update.
Daya S
Treat Endocrinol; 2004; 3(3):161-71. PubMed ID: 16026112
[TBL] [Abstract][Full Text] [Related]
19. Gonadotropin therapy in assisted reproduction: an evolutionary perspective from biologics to biotech.
Leão Rde B; Esteves SC
Clinics (Sao Paulo); 2014; 69(4):279-93. PubMed ID: 24714837
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
